Study of Docetaxel in Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: epidoxorubicine, ciclophosphamide, methotrexate, fluorouracile|DRUG: epidoxorubicine, docetaxel, ciclophosphamide, methotrexate, fluorouracile|DRUG: epidoxorubicine, docetaxel, cyclophosphamide
Sponsor: Sanofi